ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

被引：516

作者：

Garcia-Carbonero, R. ^{[1
]}

Sorbye, H. ^{[2
]}

Baudin, E. ^{[3
]}

Raymond, E. ^{[4
]}

Wiedenmann, B. ^{[5
]}

Niederle, B. ^{[6
]}

Sedlackova, E. ^{[7
,8
]}

Toumpanakis, C. ^{[9
]}

Anlauf, M. ^{[10
]}

Cwikla, J. B. ^{[11
]}

Caplin, M. ^{[12
]}

O'Toole, D. ^{[13
,14
,15
]}

Perren, A. ^{[16
]}

机构：

[1] Hosp Univ Doce Octubre, Dept Med Oncol, Ave Cordoba Km 5-4, ES-28041 Madrid, Spain

[2] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway

[3] Inst Gustave Roussy, Villejuif, France

[4] Hop Univ Paris Nord Val Seine, Oncol Med, Paris, France

[5] Charite, Dept Hepatol & Gastroenterol, Campus Virchow Klinikum, D-13353 Berlin, Germany

[6] Med Univ Vienna, Dept Surg, Vienna, Austria

[7] First Fac Med, Dept Oncol, Prague, Czech Republic

[8] Gen Teaching Hosp, Prague, Czech Republic

[9] Royal Free Hosp, Neuroendocrine Tumour Unit, Pond St, London NW3 2QG, England

[10] St Vincenz Hosp, Inst Pathol & Zytol, Limburg, Germany

[11] Univ Warmia & Mazury, Dept Radiol, Fac Med Sci, Olsztyn, Poland

[12] Royal Free Hosp, Neuroendocrine Tumour Unit, Pond St, London NW3 2QG, England

[13] St Vincents Univ, NET Ctr, Dublin, Ireland

[14] St James Hosp, Dept Clin Med, Dublin 8, Ireland

[15] Univ Dublin Trinity Coll, Dublin 2, Ireland

[16] Univ Bern, Inst Pathol, Bern, Switzerland

来源：

NEUROENDOCRINOLOGY | 2016年 / 103卷 / 02期

关键词：

NEURON-SPECIFIC ENOLASE; CELL LUNG-CANCER; PHASE-III TRIAL; PROGNOSTIC-FACTORS; CHROMOGRANIN-A; CHEMOTHERAPY; CISPLATIN; ETOPOSIDE; NEOPLASMS; PANCREAS;

D O I：

10.1159/000443172

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：186 / 194

页数：9

共 54 条

[1] ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin [J].

Agaimy, Abbas ;

Erlenbach-Wuensch, Katharina ;

Konukiewitz, Bjoern ;

Schmitt, Anja M. ;

Rieker, Ralf J. ;

Vieth, Michael ;

Kiesewetter, Franklin ;

Hartmann, Arndt ;

Zamboni, Giuseppe ;

Perren, Aurel ;

Kloeppel, Guenter .

MODERN PATHOLOGY, 2013, 26 (07) :995-1003

[2] Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? [J].

Bajetta, Emilio ;

Catena, Laura ;

Procopio, Giuseppe ;

De Dosso, Sara ;

Bichisao, Ettore ;

Ferrari, Leonardo ;

Martinetti, Antonia ;

Platania, Marco ;

Verzoni, Elena ;

Formisano, Barbara ;

Bajetta, Roberto .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (05) :637-642

[3] The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms [J].

Basturk, Olca ;

Yang, Zhaohai ;

Tang, Laura H. ;

Hruban, Ralph H. ;

Adsay, Volkan ;

McCall, Chad M. ;

Krasinskas, Alyssa M. ;

Jang, Kee-Taek ;

Frankel, Wendy L. ;

Balci, Serdar ;

Sigel, Carlie ;

Klimstra, David S. .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (05) :683-690

[4] Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas A Clinicopathologic Analysis of 44 Cases [J].

Basturk, Olca ;

Tang, Laura ;

Hruban, Ralph H. ;

Adsay, Volkan ;

Yang, Zhaohai ;

Krasinskas, Alyssa M. ;

Vakiani, Efsevia ;

La Rosa, Stefano ;

Jang, Kee-Taek ;

Frankel, Wendy L. ;

Liu, Xiuli ;

Zhang, Lizhi ;

Giordano, Thomas J. ;

Bellizzi, Andrew M. ;

Chen, Jey-Hsin ;

Shi, Chanjuan ;

Allen, Peter ;

Reidy, Diane L. ;

Wolfgang, Christopher L. ;

Saka, Burcu ;

Rezaee, Neda ;

Deshpande, Vikram ;

Klimstra, David S. .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (04) :437-447

[5] Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours [J].

Baudin, E ;

Gigliotti, A ;

Ducreux, R ;

Ropers, J ;

Comoy, E ;

Sabourin, JC ;

Bidart, JM ;

Cailleux, AF ;

Bonacci, R ;

Ruffié, P ;

Schlumberger, M .

BRITISH JOURNAL OF CANCER, 1998, 78 (08) :1102-1107

[6]

Bosman FT, 2010, WHO Classification of tumors of the digestive system, V4th

[7] Small cell carcinomas of the gastrointestinal tract: Clinicopathological features and treatment approach [J].

Brenner, Baruch ;

Tang, Laura H. ;

Shia, Jinruh ;

Klimstra, David S. ;

Kelsen, David P. .

SEMINARS IN ONCOLOGY, 2007, 34 (01) :43-50

[8]

Casas F, 1997, CANCER, V80, P1366, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1366::AID-CNCR2>3.3.CO

[9]

2-3

[10] ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms [J].

Delle Fave, G. ;

O'Toole, D. ;

Sundin, A. ;

Taal, B. ;

Ferolla, P. ;

Ramage, J. K. ;

Ferone, D. ;

Ito, T. ;

Weber, W. ;

Zheng-Pei, Z. ;

De Herder, W. W. ;

Pascher, A. ;

Ruszniewski, P. .

NEUROENDOCRINOLOGY, 2016, 103 (02) :119-124

← 1 2 3 4 5 6 →